| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | -0.0028 | 0.9 |
| mRNA | B02 | CTRPv2 | pan-cancer | AAC | -0.0026 | 1 |
| mRNA | UNC1215 | GDSC1000 | pan-cancer | AAC | 0.002 | 1 |
| mRNA | selumetinib:piperlongumine (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0021 | 1 |
| mRNA | palmostatin B | CTRPv2 | pan-cancer | AAC | 0.0028 | 1 |
| mRNA | BRD-K30019337 | CTRPv2 | pan-cancer | AAC | -0.0037 | 1 |
| mRNA | pifithrin-mu | CTRPv2 | pan-cancer | AAC | 0.0019 | 1 |
| mRNA | BEC | CTRPv2 | pan-cancer | AAC | 0.0037 | 1 |
| mRNA | KH-CB19 | CTRPv2 | pan-cancer | AAC | -0.0021 | 1 |
| mRNA | GW-2580 | GDSC1000 | pan-cancer | AAC | 0.0014 | 1 |